Benzodiazepine Drug Test (BZO/300) Dip Card Test

Fast Benzodiazepine Screening with Reliable Results

The Benzodiazepine Drug Test (BZO/300) Dip Card Test is a rapid urine screening solution designed to identify benzodiazepine metabolites quickly and efficiently. Built for professional drug testing environments, this single-panel dip card offers fast turnaround times, simple operation, and reliable preliminary screening.

Whether used in workplace programs, rehabilitation facilities, clinical settings, or monitoring programs, the BZO/300 test kit provides convenient screening without requiring laboratory equipment.

Designed for Professional Drug Screening

This benzodiazepine urine test uses immunoassay technology to detect benzodiazepine metabolites at a 300 ng/mL cutoff concentration.

The easy-to-use dip card format supports high-volume testing environments while minimizing training requirements and reducing testing time.

Common Uses for Benzodiazepine Testing

Benzodiazepine testing is commonly incorporated into:

• Workplace drug testing programs
• Rehabilitation and recovery monitoring
• Clinical screening environments
• Occupational testing programs
• Monitoring and compliance programs
• Professional toxicology screening

What Does the BZO/300 Test Detect?

The test screens for:

• Benzodiazepine metabolites in urine
• Benzodiazepine screening applications
• Professional BZO monitoring programs

This product is intended for screening purposes only.

How to Use a BZO Drug Test Kit

1. Firstly, remove the urine dip test from the sealed foil pouch.
2. After that, immerse the exposed absorbent test strips of the test into the urine sample for 5 seconds.
   Also, do not let the urine sample touch the plastic device; this could cause inconclusive drug test results.
3. Then, replace the cap over the exposed absorbent test strips of the card and lay the dip card flat on a clean surface. Wait for 5 minutes.
4. Read the results at 5 minutes. Do not read after 10 minutes.

Technical Specifications

• Drug Target: Benzodiazepine (BZO)
• Cutoff Level: 300 ng/mL
• Sample Type: Urine
• Result Time: Approximately 5 minutes
• Format: Single Panel Dip Card
• Storage Temperature: 2–30°C (36–86°F)
• Intended Use: Professional screening applications

Why Choose the Benzodiazepine Dip Card Test?

Organizations requiring efficient and reliable benzodiazepine screening need testing solutions that are easy to administer while supporting large testing volumes. The BZO/300 Dip Card Test combines speed, simplicity, and professional-grade screening capability into one convenient format.

Frequently Asked Questions

Q: What does the Benzodiazepine Drug Test (BZO/300) detect?
A: This test is designed to detect benzodiazepine metabolites in urine samples using a screening cutoff of 300 ng/mL.

Q: What does BZO/300 drug test mean?
A: BZO/300 refers to the benzodiazepine screening cutoff concentration of 300 ng/mL used for metabolite detection.

Q: How quickly are results available?
A: Preliminary results are typically available within approximately 5 minutes.

Q: What sample type is required?
A: The benzodiazepine screening test uses urine samples for screening purposes.

Q: Is this test intended for workplace drug testing?
A: Yes, this rapid BZO drug test it is commonly used for workplace testing, rehabilitation monitoring, clinical screening, and professional testing programs.

Q: Do positive results require confirmation?
A: Yes, laboratory confirmation testing is recommended for all preliminary positive results.

Q: Does this test determine impairment levels?
A: No, the test is intended for screening only and does not determine impairment.

Q: Is special equipment required?
A: No, the dip card format requires no analyzers or additional equipment.

Q: How should the test be stored?
A: Store sealed at 2–30°C (36–86°F), away from moisture and direct sunlight.

Q: Is this a single-use test?
A: Yes, the Benzodiazepine Drug Test Dip Card is intended for one-time use only.